Total Payments
$3,501
2024 Payments
$1,005
Companies
36
Transactions
185
Medicare Patients
7,477
Medicare Billing
$588,732
Payment Breakdown by Category
Food & Beverage$3,319 (94.8%)
Education$182.43 (5.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,319 | 180 | 94.8% |
| Education | $182.43 | 5 | 5.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $473.36 | 26 | $0 (2024) |
| Boston Scientific Corporation | $471.48 | 24 | $0 (2024) |
| COLOPLAST CORP | $282.31 | 10 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $253.21 | 13 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $198.26 | 11 | $0 (2024) |
| ABBVIE INC. | $187.08 | 10 | $0 (2024) |
| Endo Pharmaceuticals Inc. | $140.32 | 9 | $0 (2022) |
| Teleflex LLC | $104.84 | 6 | $0 (2024) |
| Axonics, Inc. | $96.89 | 4 | $0 (2024) |
| Medtronic, Inc. | $96.13 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,005 | 50 | Sumitomo Pharma America, Inc. ($165.58) |
| 2023 | $391.62 | 21 | Sumitomo Pharma America, Inc. ($87.63) |
| 2022 | $652.01 | 32 | Astellas Pharma US Inc ($174.58) |
| 2021 | $620.66 | 37 | Astellas Pharma US Inc ($94.23) |
| 2020 | $229.07 | 15 | Astellas Pharma US Inc ($52.72) |
| 2019 | $329.73 | 16 | Coloplast Corp ($140.97) |
| 2018 | $172.19 | 7 | BOSTON SCIENTIFIC CORPORATION ($86.48) |
| 2017 | $101.04 | 7 | Astellas Pharma US Inc ($48.27) |
All Payment Transactions
185 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: ONCOLOGY | ||||||
| 12/11/2024 | Teleflex LLC | — | Food and Beverage | In-kind items and services | $15.31 | General |
| 12/05/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $21.18 | General |
| Category: UROLOGY | ||||||
| 12/03/2024 | Myriad Genetic Laboratories, Inc. | PROLARIS (Device) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | COLOPLAST CORP | SpeediCath (Device) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Continence Care | ||||||
| 11/19/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $27.66 | General |
| Category: HORMONE THERAPY | ||||||
| 11/12/2024 | COLOPLAST CORP | Titan (Device) | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: Men's Health | ||||||
| 11/07/2024 | Tolmar, Inc. | ELIGARD (Drug), JATENZO | Food and Beverage | Cash or cash equivalent | $18.34 | General |
| Category: ONCOLOGY | ||||||
| 11/05/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: UROLOGY | ||||||
| 10/29/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 10/21/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/08/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $17.11 | General |
| Category: UROLOGY | ||||||
| 09/24/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Oncology | ||||||
| 09/17/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $28.42 | General |
| Category: UROLOGY | ||||||
| 09/17/2024 | Boston Scientific Corporation | SpaceOAR VUE System - 10mL (Device) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: SpaceOAR VUE_URO | ||||||
| 09/10/2024 | COLOPLAST CORP | SpeediCath (Device) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Continence Care | ||||||
| 09/03/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: UROLOGY | ||||||
| 08/27/2024 | PFIZER INC. | XTANDI (Drug), TALZENNA, ORGOVYX | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: ONCOLOGY | ||||||
| 08/13/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/08/2024 | Ambu Inc. | — | Food and Beverage | Cash or cash equivalent | $33.22 | General |
| 08/06/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: ONCOLOGY | ||||||
| 07/30/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $8.87 | General |
| Category: UROLOGY | ||||||
| 07/25/2024 | Boston Scientific Corporation | LithoVue (Device) | Food and Beverage | In-kind items and services | $28.41 | General |
| Category: LithoVue_URO | ||||||
| 07/23/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: HORMONE THERAPY | ||||||
| 07/16/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,266 | 3,857 | $591,990 | $168,694 |
| 2022 | 19 | 1,857 | 3,309 | $541,736 | $152,958 |
| 2021 | 21 | 1,775 | 6,132 | $508,130 | $159,290 |
| 2020 | 19 | 1,579 | 2,591 | $321,755 | $107,790 |
Total Patients
7,477
Total Services
15,889
Medicare Billing
$588,732
Procedure Codes
80
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 386 | 630 | $157,500 | $52,046 | 33.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 296 | 364 | $63,700 | $22,148 | 34.8% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 18 | 156 | $124,020 | $20,766 | 16.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 133 | 133 | $42,560 | $14,374 | 33.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 64 | 83 | $38,595 | $13,675 | 35.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 64 | 76 | $26,220 | $10,007 | 38.2% |
| 51729 | Complex measurement of pressure of urine flow in bladder with urethra pressure and voiding pressure studies | Office | 2023 | 28 | 30 | $20,280 | $8,451 | 41.7% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 17 | 18 | $14,508 | $5,570 | 38.4% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 447 | 714 | $39,270 | $4,958 | 12.6% |
| 51797 | Insertion of device into abdomen with pressure and urine flow rate study | Office | 2023 | 27 | 29 | $7,540 | $3,988 | 52.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 608 | 1,430 | $17,160 | $3,133 | 18.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 17 | 17 | $7,225 | $2,634 | 36.5% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 14 | 14 | $4,620 | $1,390 | 30.1% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 15 | 15 | $7,575 | $1,251 | 16.5% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 11 | 11 | $4,510 | $1,215 | 26.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 13 | 13 | $2,795 | $1,002 | 35.9% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 18 | 28 | $2,296 | $685.72 | 29.9% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2023 | 28 | 30 | $7,800 | $679.08 | 8.7% |
| 76942 | Ultrasonic guidance for needle placement | Facility | 2023 | 14 | 14 | $1,596 | $302.77 | 19.0% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 17 | 20 | $1,100 | $257.72 | 23.4% |
| 51741 | Electronic assessment of bladder emptying | Office | 2023 | 31 | 32 | $1,120 | $161.21 | 14.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 409 | 693 | $173,250 | $56,876 | 32.8% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 21 | 174 | $138,330 | $24,027 | 17.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 131 | 131 | $41,920 | $14,156 | 33.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 50 | 72 | $31,680 | $12,124 | 38.3% |
About Dr. Nathan Rademaker, M.D
Dr. Nathan Rademaker, M.D is a Urology healthcare provider based in Stillwater, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/12/2014. The National Provider Identifier (NPI) number assigned to this provider is 1962816413.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nathan Rademaker, M.D has received a total of $3,501 in payments from pharmaceutical and medical device companies, with $1,005 received in 2024. These payments were reported across 185 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($3,319).
As a Medicare-enrolled provider, Rademaker has provided services to 7,477 Medicare beneficiaries, totaling 15,889 services with total Medicare billing of $588,732. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Stillwater, OK
- Active Since 06/12/2014
- Last Updated 03/26/2020
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1962816413
Products in Payments
- XTANDI (Drug) $296.88
- ORGOVYX (Drug) $260.37
- LUPRON DEPOT (Drug) $171.61
- AMS (Device) $134.66
- GEMTESA (Drug) $127.18
- SPEEDICATH (Device) $113.10
- INTERSTIM (Device) $110.96
- Myrbetriq (Drug) $96.61
- JELMYTO (Drug) $90.78
- AVEED (Biological) $87.84
- AQUABEAM SYSTEM (Device) $84.59
- ADSTILADRIN (Biological) $78.28
- PROLARIS (Device) $78.13
- ELIGARD (Drug) $67.94
- Altis (Device) $61.38
- UROLIFT (Device) $60.01
- Thiola (Drug) $57.92
- Axumin (Drug) $56.64
- XIAFLEX (Biological) $56.38
- Axonics (Device) $54.97
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.